Analytical Champions: Sarah O’Keeffe
November 10, 2026
Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
14 min read
False
Advertisement
2026
Brain-Sensing CAR T Cells Target Pediatric Glioma
November 10, 2026
Engineered T cells use molecular switches to selectively attack brain tumors, demonstrating promising antitumor activity for diffuse midline glioma
2 min read
Scaling CRISPR Gene Correction for Sickle Cell Disease
November 9, 2026
Researchers establish a clinical-scale, nonviral manufacturing process that directly repairs the disease-causing HBB mutation in autologous stem cells
2 min read
Is Pharma Building the Right Facilities for Future Biologics?
November 9, 2026
As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require
5 min read
Video: The Ultimate in Translational Medicine – with Harold Keer
November 6, 2026
Power List 2026 honoree Harold Keer traces oncology’s transformation – and considers what it will take to turn today’s “abundance of riches” into better patient outcomes
1 min read
Preparing Community Hospitals for CAR T’s Expansion
November 5, 2026
By choosing where to participate and working with specialist partners, community hospitals can bring more of the CAR T patient journey closer to home
6 min read
Naive-Like T Cells Linked to CAR T Durability
November 4, 2026
Higher proportions of less-differentiated T cells were associated with longer progression-free survival in a 783-patient lymphoma analysis
1 min read
Who Funds Biotech Shapes What Gets Built
November 4, 2026
Stella Vnook explains why broader representation at the investment table can strengthen biotech, expand support for women-led companies, and accelerate innovation in women’s health
9 min read
Putting Patients in Control of Self-Injection
November 4, 2026
West Pharmaceutical Services’ Whitney Winters discusses how injection device design can support patient comfort, confidence, and independence
5 min read
BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial
November 3, 2026
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
2 min read
